InGel Therapeutics, Inc.

We are thrilled to announce that our groundbreaking cell therapy, designed to bring light back to patients affected by Retinitis Pigmentosa, has been featured by the Foundation Fighting Blindness! This spotlight on our work is a testament to the dedication and innovation of our entire team at InGel Therapeutics, Inc. Our mission is to restore sight and hope for those affected by vision loss, and this recognition fuels our drive to push the boundaries of what's possible in biotech. Check out the full article here: https://lnkd.in/gjNMziJU Deepti Singh Michael Young PhD FARVO Patrick Jiang #Biotech #CellTherapy #VisionRestoration #InGel #FoundationFightingBlindness #Innovation #Healthcare #BringingLightBack

We're looking forward to attending the Retinal Cell and Gene Therapy Innovation Summit on Friday organized by the Foundation Fighting Blindness! Leading retinal disease experts will be giving presentations on prospective gene and cell-based therapies. Our CSO, Deepti Singh, will be presenting and sharing our recent progress on creating a treatment for patients affected by Retinitis Pigmentosa. https://lnkd.in/gK5ZjTaJ Patrick Jiang Pierre Colombe Dromel

We are excited to attend Ophthalmology Innovation Source (OIS Retina) on May 4th in Seattle. Our CEO Pierre Colombe Dromel will be presenting and sharing our recent progress during the Innovation Showcase. Please come to learn more on our lead program IGT001, and its potential to restore and recover vision for patients affected by Retinitis Pigmentosa. https://lnkd.in/geVddkw4 Deepti Singh Patrick Jiang Michael Young PhD FARVO

The InGel Therapeutics, Inc. team has a very busy week ahead in Seattle. Our team will be at ARVO all week presenting some of our recent advancements to bring back light to patients affected by Retinitis Pigmentosa. We will be presenting two posters on Monday 6th and Wednesday 8th so come take a look! Please do not hesitate to contact us if you would like to know more about our program. Be on the look-out for other announcements. https://lnkd.in/gsPuQE7 Deepti Singh Patrick Jiang Pierre Colombe Dromel

We are excited to attend Eyecelerator @ASCRS on April 4th in Boston. Our CEO?Pierre Colombe Dromel?will be presenting during the Winning Pitch Challenge (Shark Tank-style competition features pitches from three ophthalmology innovators). Please come to learn more on our lead program IGT001, and its potential to restore and recover vision for patients affected by Retinitis Pigmentosa. Patrick Jiang Deepti Singh Michael Young PhD FARVO #Retina #RetinitisPigmentosa #ASCRS #BLINDNESS https://lnkd.in/gE2Q6zgj

As the year draws to a close, we at InGel Therapeutics, Inc. want to extend our warmest holiday greetings to everyone. ?? ?? Happy Holidays and a Happy New Year! ?? Reflecting on 2023, it's been an incredibly busy yet fulfilling year for us. We've reached numerous milestones that mark significant progress in our journey. However, none of this would have been possible without the amazing support we've received from mentors, advisors, investors, and friends of InGel. As we look ahead to 2024, we're excited for the new challenges and opportunities that await. We remain committed to our goal and optimistic about what the future holds. Here's to a year of health, happiness, and breakthroughs! ?? Cheers to 2024! Deepti Singh, Patrick Jiang, Pierre Colombe Dromel